OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ESC/EAS Guidelines for the management of dyslipidaemias
Alberico L. Catapano, Željko Reiner, Guy De Backer, et al.
Atherosclerosis (2011) Vol. 217, Iss. 1, pp. 3-46
Closed Access | Times Cited: 700

Showing 1-25 of 700 citing articles:

Dyslipidemia in Obesity: Mechanisms and Potential Targets
Boudewijn Klop, J ELTE, Manuel Castro Cabezas
Nutrients (2013) Vol. 5, Iss. 4, pp. 1218-1240
Open Access | Times Cited: 1436

Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity
Paulina Salminen, Mika Helmiö, Jari Ovaska, et al.
JAMA (2018) Vol. 319, Iss. 3, pp. 241-241
Open Access | Times Cited: 824

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Terry A. Jacobson, Kevin C. Maki, Carl E. Orringer, et al.
Journal of clinical lipidology (2015) Vol. 9, Iss. 6, pp. S1-S122.e1
Open Access | Times Cited: 742

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, et al.
Journal of clinical lipidology (2015) Vol. 9, Iss. 2, pp. 129-169
Closed Access | Times Cited: 726

Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
Seth S. Martin, Michael J. Blaha, Mohamed B. Elshazly, et al.
JAMA (2013) Vol. 310, Iss. 19, pp. 2061-2061
Open Access | Times Cited: 710

The Agenda for Familial Hypercholesterolemia
Samuel S. Gidding, Mary Ann Champagne, Sarah D. de Ferranti, et al.
Circulation (2015) Vol. 132, Iss. 22, pp. 2167-2192
Closed Access | Times Cited: 609

Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication
Marianne Benn, Gerald F. Watts, Anne Tybjærg‐Hansen, et al.
The Journal of Clinical Endocrinology & Metabolism (2012) Vol. 97, Iss. 11, pp. 3956-3964
Open Access | Times Cited: 588

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary
Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, et al.
Journal of clinical lipidology (2014) Vol. 8, Iss. 5, pp. 473-488
Open Access | Times Cited: 454

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome
Barbara Sjouke, D. Meeike Kusters, Iris Kindt, et al.
European Heart Journal (2014) Vol. 36, Iss. 9, pp. 560-565
Open Access | Times Cited: 410

Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications
Seth S. Martin, Michael J. Blaha, Mohamed B. Elshazly, et al.
Journal of the American College of Cardiology (2013) Vol. 62, Iss. 8, pp. 732-739
Closed Access | Times Cited: 394

Genetic identification of familial hypercholesterolemia within a single U.S. health care system
Noura S. Abul‐Husn, Kandamurugu Manickam, Laney K. Jones, et al.
Science (2016) Vol. 354, Iss. 6319
Closed Access | Times Cited: 394

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
Klaus G. Parhofer
Diabetes & Metabolism Journal (2015) Vol. 39, Iss. 5, pp. 353-353
Open Access | Times Cited: 371

Statin use and non-alcoholic steatohepatitis in at risk individuals
Paola Dongiovanni, Salvatore Petta, Ville Männistö, et al.
Journal of Hepatology (2015) Vol. 63, Iss. 3, pp. 705-712
Closed Access | Times Cited: 354

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
Scott M. Grundy, Hidenori Arai, Philip J. Barter, et al.
Journal of clinical lipidology (2013) Vol. 7, Iss. 6, pp. 561-565
Closed Access | Times Cited: 347

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
Scott M. Grundy, Hidenori Arai, Philip J. Barter, et al.
Journal of clinical lipidology (2013) Vol. 8, Iss. 1, pp. 29-60
Open Access | Times Cited: 312

Diabetes and lipid metabolism
Vasilios G. Athyros, Michael Doumas, Κonstantinos Imprialos, et al.
HORMONES (2018) Vol. 17, Iss. 1, pp. 61-67
Open Access | Times Cited: 291

The Role of Nutraceuticals in Statin Intolerant Patients
Maciej Banach, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Journal of the American College of Cardiology (2018) Vol. 72, Iss. 1, pp. 96-118
Open Access | Times Cited: 248

Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity
Paulina Salminen, Sofia Grönroos, Mika Helmiö, et al.
JAMA Surgery (2022) Vol. 157, Iss. 8, pp. 656-656
Open Access | Times Cited: 232

Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis
Simon B. Pedersen, Anne Langsted, Børge G. Nordestgaard
JAMA Internal Medicine (2016) Vol. 176, Iss. 12, pp. 1834-1834
Closed Access | Times Cited: 226

Berberine and Its Role in Chronic Disease
Arrigo F.G. Cicero, Alessandra Baggioni
Advances in experimental medicine and biology (2016), pp. 27-45
Closed Access | Times Cited: 221

Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease
Robert S. Rosenson, Michael H. Davidson, Benjamin J. Hirsh, et al.
Journal of the American College of Cardiology (2014) Vol. 64, Iss. 23, pp. 2525-2540
Open Access | Times Cited: 219

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Peter P. Tóth
Vascular Health and Risk Management (2016), pp. 171-171
Open Access | Times Cited: 199

Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis
Feng Sun, Shanshan Wu, Jing Wang, et al.
Clinical Therapeutics (2014) Vol. 37, Iss. 1, pp. 225-241.e8
Closed Access | Times Cited: 193

Novel methodologies for biomarker discovery in atherosclerosis
Imo E. Hoefer, Sabine Steffens, Mika Ala‐Korpela, et al.
European Heart Journal (2015) Vol. 36, Iss. 39, pp. 2635-2642
Open Access | Times Cited: 186

Page 1 - Next Page

Scroll to top